Arkema (OTCMKTS:ARKAY - Get Free Report) will likely be releasing its earnings data on Tuesday, May 6th. Analysts expect Arkema to post earnings of $1.45 per share and revenue of $2.44 billion for the quarter.
Arkema Stock Up 0.4 %
Shares of OTCMKTS:ARKAY opened at $75.75 on Tuesday. The firm has a market capitalization of $5.76 billion, a P/E ratio of 15.15, a P/E/G ratio of 0.53 and a beta of 1.18. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.54 and a current ratio of 2.11. The stock has a 50 day moving average price of $78.82 and a 200-day moving average price of $80.20. Arkema has a 52-week low of $64.94 and a 52-week high of $111.13.
Analyst Upgrades and Downgrades
Separately, Sanford C. Bernstein began coverage on Arkema in a research report on Thursday. They set an "underperform" rating for the company.
View Our Latest Stock Analysis on Arkema
About Arkema
(
Get Free Report)
Arkema SA manufactures and sells specialty chemicals and advanced materials worldwide. The company operates in three segments: Adhesive Solutions, Advanced Materials and Coating Solutions, and Intermediates. The Adhesive Solutions segment provides solutions for construction, renovation of buildings, DIY, durable goods, and packaging and non-woven applications; and supplies technologies used in building activities for businesses and individuals, including sealants, tiles, flooring adhesives and waterproofing systems, and technologies used in industry, which include automotive, textiles, glazing, flexible and rigid packaging, and hygiene markets.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Arkema, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arkema wasn't on the list.
While Arkema currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
